Cosmo Pharmaceuticals N.V. carries a market capitalization of 978.14M, placing it among publicly traded companies globally.
| Market Cap | 978.14M |
| Enterprise Value | N/A |
Cosmo Pharmaceuticals N.V.'s stock has declined approximately -0.3502627% over the past 52 weeks. The 50-day moving average sits at 64.72, while the 200-day moving average is 85.18.
| Beta (5Y) | N/A |
| 52-Week Price Change | -0.3502627% |
| 50-Day Moving Average | 64.72 |
| 200-Day Moving Average | 85.18 |
| Average Volume (20 Days) | N/A |